Technologies 2018

Technologies marked with an * will be presented orally.


Synthetic lignans targeting cardiovascular diseases

Prof. Marko Mihovilovic, Dr Thomas Linder, Prof. Verena M. Dirsch, Dr David Bernhard, Prof. Hermann Stuppner
Austria Wirtschaftsservice


Atomizer – new technology for production of micro- and nanoparticles

Miloš Beran, Dr Josef Drahorád, Zdenek Husek


Diagnosing osteoporosis with CortBS

Prof. Kay Raum, Dr Juan Du, Gianluca Iori

CD1a as a diagnostic marker and therapeutic target for Ulcerative Colitis

Dr Roswitha Gropp, Prof. Matthias Siebeck, Michael Föhlinger, Dr Pia Palamides
Bayerische Patentallianz

New diagnostic method for colorectal cancer

Dr Gabriella Mattei, Dr Rossella Solmi, Dr Mattia Lauriola, Dr Giampaolo Ugolini, Dr Isacco Montroni, Dr Maria Teresa Rodia

New highly selective interface for phosphoproteome profiling

Prof. Zuzana Bílková, Dr Jan Macák, Rudolf Kupčik, Dr Pavel Řehulka
University of Pardubice

A method for early diagnosis of pancreatic cancer

Prof. Michal Holčapek, Dr Eva Cífková, Dr Miroslav Lísa, Dr Denise Wolrab, Dr Robert Jirásko
University of Pardubice

BioPersMed Metabolic and Cardio Cohort

Prof. Albrecht Schmidt, Prof. Barbara Obermayer-Pietsch
Austria Wirtschaftsservice

Marker-free, high-content screening for digital pathology

Prof. Rudolf Kessler, Dr Edwin Ostertag, Jörg-Walter Bartsch, Rainer Ritz

Highly selective modification and detection of epigenetic target nucleobases via tailored TALEs

Prof. Daniel Summerer, Grzegorz Kubik, Sara Maurer, Mario Gieß

Biomarker for the assessment of physical fitness

Prof. Jessica Bertrand, Prof. Christoph Lohmann, Karsten Pinno, Dr Margit Rudolf

Integrated platform for liquid biopsy-based personalized cancer medicine

Dr Kamran Honarnejad, Dr Stefan Kirsch, Prof. Christoph Klein, Dr Bernhard Polzer, Dr Christian Werno

Digital Health

Wound Viewer: system for monitoring chronic wounds

Dr Jacopo Secco, Dr Marco Farina


Small molecules MALT1 inhibitors as therapeutics for B cell lymphoma and inflammation

Prof. Margot Thome, Dr Ming Zhang, Dr Barbara Saxty, Dr Sururat Adigun, Dr Lisa Hale

Oligomeric vaccines

Prof. Udo Conrad, Dr Hoang Trong Phan, Thuong Ho


Novel treatment for septic diseases in newborns

Prof. Dorothee Viemann, Prof. Johannes Roth, Prof. Thomas Vogl

Chemical disruption of the ClpX chaperone complex inhibits multiresistant Staphylococcus aureus virulence

Dr Christian Fetzer, Dr Vadim Krotokov, Prof. Stephan Sieber
Bayerische Patentallianz

Cystobactamide – novel antibacterials against gram-negative pathogens

Prof. Rolf Müller, Prof. Rolf Hartmann, Prof. Andreas Kirschning, Prof. Mark Brönstrup

Corallopyronin A – an antibiotic active against Helminths, Staphylococci and STIs

Prof. Achim Hoerauf, Dr Stefan Kehraus, Prof. Gabriele Maria König, Dr Kenneth Pfarr, Dr Andrea Schiefer

Safe and effective preventative Epstein-Barr Virus (EBV) vaccine (P-989/1309)

Prof. Henri-Jacques Delecluse, Dr Anatoliy Shumilov, Ming-Han Tsai

Novel anti-tuberculosis compounds

Dr Oliver Koch, Luis Bering

EF-Tu-binding Re-complex antibiotics

Prof. Nils Metzler-Nolte, Prof. Julia Bandow, Sina Schäkermann, Daniel Siegmund

Anti-tuberculosis drug

Dr Jan Rybniker, Prof. Stewart Cole

Treatment of Sepsis and Acute Respiratory Distress Syndrome (ARDS)

Prof. Valery Bochkov, Dr Olga Oskolkova
Austria Wirtschaftsservice


Matriptase inhibitor for utility in Osteoarthritis as disease modifying therapy

Dr Drew Rowan, Dr Tim Chapman, Dr Lorna Duffy, Dr Prem Meghani


Dipeptide repeat specific antibodies as immunotherapeutic option to treat C9orf72 patients

Prof. Christian Haass, Dr Kohji Mori, Dr Thomas Arzberger, Dr Elisabeth Kremmer, Prof. Dieter Edbauer

Tacrine derivative as a potent and selective GLU2b antagonist for the treatment of neurodegenerative diseases

Dr Jan Korábečný, Dr Ondřej Soukup, Dr Martin Horák, Dr Karel Valeš
Centre for Transfer of Biomedical Technologies

Benzothiazole-based ureas as potential ABAD/17beta-HSD10 modulators for Alzheimer’s disease treatment

Dr Kamil Musílek, Dr Ondřej Benek, Dr Lukáš Hroch
Centre for Transfer of Biomedical Technologies

Steroids as allosteric modulators of NMDAR for neuropathic pain treatment

Dr Eva Kudová, Prof. Ladislav Vyklický, Dr Jiří Paleček

A humanised antibody that specifically targets truncated/toxic species of Aβ for Alzheimer’s Disease

Prof. Thomas Bayer, Dr David Matthews, Dr Janet Brownlees, Dr Preeti Bakrania

S-Oxprenolol for treating amyotrophic lateral sclerosis (ALS)

Dr Jochen Springer, Prof. Stefan Anker, Prof. Andrew Coats


Innovative nerve sheath tumor therapy

Dr Alexander Schulz, Dr Helen Morrison

CXCR6-transduced T cells for targeted tumor therapy

Dr Sebastian Kobold, Prof. Stefan Endres, Moritz Rapp, Simon Grassmann
Bayerische Patentallianz

Enhancing effect of ATM/ATR/DNA-PK inhibitors on oncology treatment with standard chemotherapeutics

Dr Jan Korábečný, Dr Martin Andrš, Dr Ondřej Soukup, Prof. Martina Řezáčová, Dr Martina Seifrtová
Centre for Transfer of Biomedical Technologies

Peptide vaccine for treatment of IDH1 R132H mutant-positive cancers (P-987)

Prof. Michael Platten, Prof. Wolfgang Wick, Dr Theresa Schuhmacher

Therapeutic Interleukin 11 antibody

Dr Reimar Abraham, Dr Johannes Bange, Prof. Matthias Ernst, Dr Tracy Putoczki
Lead Discovery Center

New inhibitors of Exon 20 mutations

Dr Roman Thomas, Dr Daniel Rauh, Dr Carsten Schulz-Fademrecht, Dr Bert Klebl
Lead Discovery Center

Immunoproteasome inhibitors

Dr Robert Huber, Dr Uwe Koch, Dr Bert Klebl
Lead Discovery Center

Nanoconstruct for antitumor therapy

Dr Andrea Ancona, Dr Marta Canta, Dr Bianca Dumontel, Dr Tania Limongi, Dr Valentina Cauda, Dr Giancarlo Canavese, Dr Nadia Garino, Dr Marco Laurenti, Dr Luisa Racca

Inhibition of IKK complex

Prof. Christian Kaltschmidt, Prof. Barbara Kaltschmidt, Dr Johannes Greiner, Carsten Slotta, Jonathan Storm

A new strategy for the treatment of Fibrosis related diseases

Prof. Donald Gullberg
Bergen Teknologioverføring BTO

Novel chalcone derivative for cancer treatment

Dr Katrina Vanura, Prof. Ulrich Jäger, Prof. Thomas Erker, Dr Gerda Brunhofer-Bolzer
Austria Wirtschaftsservice


Treatment of PCOS or oligo-ovulatory androgen excess in women

Prof. Francis De Zegher, Prof. Lourdes Ibanez
KU Leuven

Electrospun nanofibrous multiscale scaffold for tendon and ligament tissue regeneration and replacement

Dr Andrea Zucchelli, Dr Alberto Sensini, Dr Luca Cristofolini, Dr Chiara Gualandi, Dr Maria Letizia Focarete, Dr Juri Belcari

Chemokine-loaded microparticles in hyaluronic acid for treatment of osteoarthritis

Dr Jochen Ringe, Dr Kristin Fröhlich, Prof. Michael Sittinger


Innovative method for detecting co-occurring histone modifications in a single step using hybrid proteins

Prof. Albert Jeltsch, Goran Kungulovski, Rebekka Mauser

Low cost cloning

Dr Sylvestre Marillonnet



23 - 24 April 2018, Munich

Please subscribe to our free news service to receive future information updates on BioVaria.

!!! Stay informed

Esther Lange
Ascenion GmbH
T: +49 89 318814-22
E: info(at)
Tw: @BioVaria